A number of eukaryotic expression vectors have been developed for use as DNA vaccines. They showed varying abilities to initiate immune responses; however, there is little data to indicate which of these vectors will be the most useful and practical for DNA vaccines in different species. This report examines the use of five expression vectors with different promoters and Kozak sequence to express the same hemagglutinin (HA) protein of an H6N2 avian influenza virus for DNA vaccination in chickens. Although intramuscular vaccination with seven DNA constructs elicited no or limited measurable H6 HA antibody responses in Hy-Line chickens, variable reduction in virus shedding for either oropharyngeal or cloacal swabs post-virus challenge were observed. This indicated that all DNA constructs generated some levels of protective immunity against homologous virus challenge. Interestingly, lower dose (50 or 100 μg) of plasmid DNAs consistently induced better immune response than higher dose (300 or 500 μg). In the transfection experiments there appeared to be a hierarchy in the in vitro expression efficiency in the order of pCAG-optiHAk/ pCAG-HAk > pCI-HAk > VR-HA > pCI-HA > pCI-neo-HA > pVAX-HA. Since the level of in vitro expression correlates with the level of immune response in vivo, in vitro expression levels of the DNA constructs can be used as an indicator for pre-selection of plasmid vaccines prior to in vivo assessment. Moreover, our results suggested that the Kozak sequence could be used as an effective tool for DNA vaccine design.
KeywordsDNA VaccineMultiple Expressing VectorsH6N2 Avian Influenza a VirusChickens
Gurunathan, S., Klinman, D.M. and Seder, R.A. (2000) DNA Vaccines: Immunology, Application, and Optimization. The Annual Review of Immunology, 18, 927-974. http://dx.doi.org/10.1146/annurev.immunol.18.1.927
Miller, M., Rekas, G., Dayball, K., Wan, Y.H. and Bramson, J. (2004) The Efficacy of Electroporated Plasmid Vaccines Correlates with Long-Term Antigen Production in Vivo. Vaccine, 22, 2517-2523. http://dx.doi.org/10.1016/j.vaccine.2004.01.019
Chen, H., Yu, K., Jiang, Y. and Tang, X. (2001) DNA Immunization Elicits High HI Antibody and Protects Chicken from AIV Challenge. International Congress Series, 1219, 917-921. http://dx.doi.org/10.1016/S0531-5131(01)00368-5
Cherbonnel, M., Rousset, J. and Jestin, V. (2003) Strategies to Improve Protection against Low-Pathogenicity H7 Avian Influenza Virus Infection Using DNA Vaccines. Avian Diseases, 47, 1181-1186. http://dx.doi.org/10.1637/0005-2086-47.s3.1181
Jiang, Y., Yu, K., Zhang, H., Zhang, P., Li, C., Tian, G., Li, Y., Wang, X., Ge, J., Bu, Z. and Chen, H. (2007) Enhanced Protective Efficacy of H5 Subtype Avian Influenza DNA Vaccine with Codon Optimized HA Gene in a pCAGGS Plasmid Vector. Antiviral Research, 75, 234-241. http://dx.doi.org/10.1016/j.antiviral.2007.03.009
Kodihalli, S., Haynes, J.R., Robinson, H.L. and Webster, R.G. (1997) Cross-Protection among Lethal H5N2 Influenza Viruses Induced by DNA Vaccine to the Hemagglutinin. Journal of Virology, 71, 3391-3396.
Kodihalli, S., Kobasa, D.L. and Webster, R.G. (2000) Strategies for Inducing Protection against Avian Influenza A Virus Subtypes with DNA Vaccines. Vaccine, 18, 2592-2599. http://dx.doi.org/10.1016/S0264-410X(99)00485-5
Suarez, D.L. and Schultz-Cherry, S. (2000) The Effect of Eukaryotic Expression Vectors and Adjuvants on DNA Vaccines in Chickens Using an Avian Influenza Model. Avian Diseases, 44, 861-868. http://dx.doi.org/10.2307/1593058
Barry, M.A. and Johnston, S.A. (1997) Biological Features of Genetic Immunization. Vaccine, 15, 788-791. http://dx.doi.org/10.1016/S0264-410X(96)00265-4
Doria-Rose, N.A. and Haigwood, N.L. (2003) DNA Vaccine Strategies: Candidates for Immune Modulation and Immunization Regimens. Methods, 31, 207-216. http://dx.doi.org/10.1016/S1046-2023(03)00135-X
Babiuk, L.A., Pontarollo, R., Babiuk, S., Loehr, B. and van Drunen Littel-van den Hurk, S. (2003) Induction of Immune Responses by DNA Vaccines in Large Animals. Vaccine, 21, 649-658. http://dx.doi.org/10.1016/S0264-410X(02)00574-1
Chen, Z., Matsuo, K., Asanuma, H., Takahashi, H., Iwasaki, T., Suzuki, Y., Aizawa, C., Kurata, T. and Tamura, S. (1999) Enhanced Protection against a Lethal Influenza Virus Challenge by Immunization with Both Hemagglutinin- and Neuraminidase-Expressing DNAs. Vaccine, 17, 653-659. http://dx.doi.org/10.1016/S0264-410X(98)00247-3
Davis, H.L., Whalen, R.G. and Demeneix, B.A. (1993) Direct Gene Transfer into Skeletal Muscle in Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression. Human Gene Therapy, 4, 151-159. http://dx.doi.org/10.1089/hum.1993.4.2-151
Galvin, T.A., Muller, J. and Khan, A.S. (2000) Effect of Different Promoters on Immune Responses Elicited by HIV-1 Gag/Env Multigenic DNA Vaccine in Macaca Mulatta and Macaca Nemestrina. Vaccine, 18, 2566-2583. http://dx.doi.org/10.1016/S0264-410X(99)00569-1
Dupuis, M., Denis-Mize, K., Woo, C., Goldbeck, C., Selby, M.J., Chen, M., Otten, G.R., Ulmer, J.B., Donnelly, J.J., Ott, G. and McDonald, D.M. (2000) Distribution of DNA Vaccines Determines Their Immunogenicity after Intramuscular Injection in Mice. The Journal of Immunology, 165, 2850-2858. http://dx.doi.org/10.4049/jimmunol.165.5.2850
Wang, S., Zhang, C., Zhang, L., Li, J., Huang, Z. and Lu, S. (2008) The Relative Immunogenicity of DNA Vaccines Delivered by the Intramuscular Needle Injection, Electroporation and Gene Gun Methods. Vaccine, 26, 2100-2110. http://dx.doi.org/10.1016/j.vaccine.2008.02.033
Garmory, H.S., Brown, K.A. and Titball, R.W. (2003) DNA Vaccines: Improving Expression of Antigens. Genetic Vaccines and Therapy, 1, 2. http://dx.doi.org/10.1186/1479-0556-1-2
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.D., Silverman, G.J., Lotz, M., Carson, D.A. and Raz, E. (1996) Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization. Science, 273, 352-354. http://dx.doi.org/10.1126/science.273.5273.352
Epstein, S.L., Tumpey, T.M., Misplon, J.A., Lo, C.Y., Cooper, L.A., Subbarao, K., Renshaw, M., Sambhara, S. and Katz, J.M. (2002) DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective against H5N1 Challenge Infection in Mice. Emerging Infectious Diseases, 8, 796-801. http://dx.doi.org/10.3201/eid0805.010476
Epstein, S.L., Kong, W.P., Misplon, J.A., Lo, C.Y., Tumpey, T.M., Xu, L. and Nabel, G.J. (2005) Protection against Multiple Influenza A Subtypes by Vaccination with Highly Conserved Nucleoprotein. Vaccine, 23, 5404-5410. http://dx.doi.org/10.1016/j.vaccine.2005.04.047
Laddy, D.J., Yan, J., Corbitt, N., Kobasa, D., Kobinger, G.P. and Weiner, D.B. (2007) Immunogenicity of Novel Consensus-Based DNA Vaccines against Avian Influenza. Vaccine, 25, 2984-2989. http://dx.doi.org/10.1016/j.vaccine.2007.01.063
Chen, Z., Sahashi, Y., Matsuo, K., Asanuma, H., Takahashi, H., Iwasaki, T., Suzuki, Y., Aizawa, C., Kurata, T. and Tamura, S. (1998) Comparison of the Ability of Viral Protein-Expressing Plasmid DNAs to Protect against Influenza. Vaccine, 16, 1544-1549. http://dx.doi.org/10.1016/S0264-410X(98)00043-7
Shan, S.H. (2010) Development and Evaluation of DNA Vaccines in Chickens against a Wild Bird H6N2 Avian Influenza Virus from Western Australia. Ph.D. Dissertation, Murdoch University, Perth.
Shan, S., Jiang, Y., Bu, Z., Ellis, T., Zeng, X., Edwards, J., Tian, G., Li, Y., Ge, J., Chen, H. and Fenwick, S. (2011) Strategies for Improving the Efficacy of a H6 Subtype Avian Influenza DNA Vaccine in Chickens. Journal of Virological Methods, 173, 220-226. http://dx.doi.org/10.1016/j.jviromet.2011.02.008
Sambrook, J. and Russell, D.W. (2001) Molecular Cloning: A laboratory Manual. 3rd Edition, Cold Spring Harbor Laboratory Press, New York, 1.31-31.42 and 31.59-31.61.
Pant, G.R. and Selleck, P.W. (2007) Surveillance for Avian Influenza in Nepal 2004-2005. Avian Diseases, 51, 352-354. http://dx.doi.org/10.1637/7649-051806R.1
Shan, S., Ellis, T.M., Fenwick, S., Edwards, J., O’Dea, M. and Parkinson, J. (2010b) Biological and Genetic Characterization of a Low-Pathogenicity Avian Influenza H6N2 Virus Originating from a Healthy Eurasian Coot. Archives of Virology, 155, 403-409. http://dx.doi.org/10.1007/s00705-010-0588-1
James, C.M., Foong, Y.Y., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2007) Use of Tetanus Toxoid as a Differentiating Infected from Vaccinated Animals (DIVA) Strategy for Sero-Surveillance of Avian Influenza Virus Vaccination in Poultry. Vaccine, 25, 5892-5901. http://dx.doi.org/10.1016/j.vaccine.2007.05.023
Lee, C.W., Senne, D.A. and Suarez, D.L. (2003) Development of Hemagglutinin Subtypespecific Reference Antisera by DNA Vaccination of Chickens. Avian Diseases, 47, 1051-1056. http://dx.doi.org/10.1637/0005-2086-47.s3.1051
Melkebeek, V., Sonck, E., Verdonck, F., Goddeeris, B.M. and Cox, E. (2007) Optimized FaeG Expression and a Thermolabile Enterotoxin DNA Adjuvant Enhance Priming of an Intestinal Immune Response by an FaeG DNA Vaccine in Pigs. Clinical and Vaccine Immunology, 14, 28-35. http://dx.doi.org/10.1128/CVI.00268-06
Uchijima, M., Yoshida, A., Nagata, T. and Koide, Y. (1998) Optimization of Codon Usage of Plasmid DNA Vaccine is Required for the Effective MHC Class I-Restricted T Cell Responses against an Intracellular Bacterium. The Journal of Immunology, 161, 5594-5599.
van Drunen Littel-van den Hurk, S., Braun, R.P., Karvonen, B.C., King, T., Yoo, D. and Babiuk, L.A. (1999) Immune Responses and Protection Induced by DNA Vaccines Encoding Bovine Parainfluenza Virus Type 3 Glycoproteins. Virology, 260, 35-46. http://dx.doi.org/10.1006/viro.1999.9793
Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A. and Felgner, P.L. (1990) Direct Gene Transfer into Mouse Muscle in Vivo. Science, 247, 1465-1468. http://dx.doi.org/10.1126/science.1690918
Steinberg, T., Ohlschlager, P., Sehr, P., Osen, W. and Gissmann, L. (2005) Modification of HPV 16 E7 Genes: Correlation between the Level of Protein Expression and CTL Response after Immunization of C57BL/6 Mice. Vaccine, 23, 1149-1157. http://dx.doi.org/10.1016/j.vaccine.2004.08.027